Showing results (321-330 of 385) with videos related to

Sort By:
Pageof 39
Bone|January 26, 2017
Teriparatide attenuates scarring around murine cranial bone allograft via modulation of angiogenesisDoron Cohn Yakubovich, Uzi Eliav, Eran Yalon, et al.
BMC Oral Health|November 24, 2020
Interprofessional collaboration and smartphone use as promising strategies to improve prenatal oral health care utilization among US underserved women: results from a qualitative studyLin Wang, Johana Ren, Kevin A Fiscella, et al.
Vaccine|July 13, 2004
Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccineDarron R Brown, Kenneth H Fife, Cosette M Wheeler, et al.
Journal of Hepatology|April 22, 2015
Grazoprevir and elbasvir plus ribavirin for chronic HCV genotype-1 infection after failure of combination therapy containing a direct-acting antiviral agentXavier Forns, Stuart C Gordon, Eli Zuckerman, et al.
The Lancet. Gastroenterology & Hepatology|June 4, 2017
Elbasvir plus grazoprevir in patients with hepatitis C virus infection and stage 4-5 chronic kidney disease: clinical, virological, and health-related quality-of-life outcomes from a phase 3, multicentre, randomised, double-blind, placebo-controlled trialAnnette Bruchfeld, David Roth, Paul Martin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2015
Grazoprevir, Elbasvir, and Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection After Failure of Pegylated Interferon and Ribavirin With an Earlier-Generation Protease Inhibitor: Final 24-Week Results From C-SALVAGEMaria Buti, Stuart C Gordon, Eli Zuckerman, et al.
Hepatology (Baltimore, Md.)|October 23, 2016
Short-duration treatment with elbasvir/grazoprevir and sofosbuvir for hepatitis C: A randomized trialEric Lawitz, Fred Poordad, Julio A Gutierrez, et al.
Molecular Therapy. Nucleic Acids|June 13, 2022
Intermittent lipid nanoparticle mRNA administration prevents cortical dysmyelination associated with arginase deficiencySuhail Khoja, Xiao-Bo Liu, Brian Truong, et al.
Annals of Internal Medicine|April 25, 2015
Grazoprevir-Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection: A Randomized TrialStefan Zeuzem, Reem Ghalib, K Rajender Reddy, et al.
Clinical and Diagnostic Laboratory Immunology|August 9, 2005
Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18Dennis Dias, Jeff Van Doren, Sonela Schlottmann, et al.
Pageof 39